Co-administration of AYUSH 64 as an adjunct to standard of care in mild and moderate COVID-19: A randomized, controlled, multicentric clinical trial.

<h4>Objective</h4>Evaluate the efficacy of AYUSH 64, a standard polyherbal Ayurvedic drug in COVID-19.<h4>Methods</h4>During the first pandemic wave, 140 consenting and eligible hospitalized adult participants with mild-moderate symptomatic disease (specific standard RT-PCR assay positive) were sele...

Descripció completa

Dades bibliogràfiques

Autors principals:	Arvind Chopra, Girish Tillu, Kuldeep Chuadhary, Govind Reddy, Alok Srivastava, Muffazal Lakdawala, Dilip Gode, Himanshu Reddy, Sanjay Tamboli, Manjit Saluja, Sanjeev Sarmukaddam, Manohar Gundeti, Ashwini Kumar Raut, B C S Rao, Babita Yadav, Narayanam Srikanth, Bhushan Patwardhan
Format:	Artigo
Idioma:	Inglês
Publicat:	Public Library of Science (PLoS) 2023-01-01
Col·lecció:	PLoS ONE
Accés en línia:	https://doi.org/10.1371/journal.pone.0282688
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!